It is not completely clear whether ECV is a better tool for risk stratifying patients with HFpEF
than renal function, N-terminal prohormone of brain natriuretic peptide levels, or other CMR …

In this issue of the journal, Shono et al.[1] report on the ability of leg-positive pressure (LPP)
stress echocardiography to differentiate between patients with heart failure and preserved …

Heart failure with preserved ejection fraction (HFpEF) represents a complex clinical
syndrome, often very difficult to diagnose using the available tools. As the global burden of …

Heart failure with preserved ejection fraction (HFpEF) is highly prevalent, affecting
approximately half of all patients with heart failure. 1 It is a significantly heterogeneous …

Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart
failure cases and has a prevalence that is expected to rise with the growing ageing …

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder
developing from multiple aetiologies with overlapping pathophysiological mechanisms …

Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent
phenotype affecting over half of today's heart failure patients. With no proven therapy and no …

24 Circulation Research January 5, 2018 the cornerstone of HFpEF. 1 In reality, one should
keep in mind considerable limitations of the conventional echocardiographic tools for …

Heart failure with preserved ejection fraction (HFpEF) does not exist as a singular clinical or
pathological entity but as a syndrome encompassing a wide range of clinical and biological …

Heart failure with a preserved ejection fraction (HFpEF) is increasingly prevalent and a
leading cause of morbidity and mortality worldwide. HFpEF has a complex pathophysiology …